Orion Corp - Company Profile
Powered by
All the data and insights you need on Orion Corp in one report.
- Save hours of research time and resources with
our up-to-date Orion Corp Strategy Report
- Understand Orion Corp position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Orion Corp Catalyst Calendar
Proactively evaluate Orion Corp’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.
A sample of Orion Corp Catalyst Calendar data
Event Date | Event Type | Company Name | Ticker Symbol | Drug Name | Therapy Area | Indication | Source Type |
---|---|---|---|---|---|---|---|
04 Mar 2020 | GDCTWXYZ | Lorem | Lorem | Lorem | WXYZ | Planned | Lorem |
20 Feb 2020 | Phase II/III Trial Initiation | Canary Foundation; CRO TRIDE Asesores SL; Dr. Negrin University Hospital; Leon Research SL; Mario Negri Institute for Pharmacological Research; Negrin Hospital Farmacy; Orion Corp; QBE Europe SA/NV | ORNBV | levosimendan | Cardiovascular | Low Cardiac Output Syndrome | Clinical Trial Registry |
10 Dec 2019 | Regulatory Approval (EU) | Orion Corp | ORNBV | darolutamide | Oncology | Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer | GD Estimates |
01 Dec 2019 | Phase I/II Trial Completion | Orion Corp | ORNBV | ODM-207 | Oncology | Metastatic Cancer; Solid Tumor | Clinical Trial Registry |
Feature
Catalyst Calendar provides forecasted drug development milestones within the Pharma industry including expected timing, expected outcomes and possible financial impacts.
Benefit
Access:
- Trial Events for trials conducted globally by a company, university, institute or CRO: Trial Initiation, Trial Completion, Trial Results
- Regulatory Events related to drug filings with regulatory bodies, approvals and commercial launches. This is covered for the US, EU and Japan
- Intellectual Property Events for patent and exclusivity expiry specific to the US, EU and Japan: Constraining Patent Expiry (US/EU/Japan), Drug Expiry (US/EU/Japan), Commercial Launch (US/EU/Japan)
Value
Proactively evaluate companies and catalyst impacts
Stay ahead of the competition & improve corporate planning
Bolster business development with timely opportunities
Premium databases is part of our industry range of products
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer